Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Mainz Biomed N.V. (MYNZ)

Mainz Biomed N.V. (MYNZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,442
  • Shares Outstanding, K 8,584
  • Annual Sales, $ 890 K
  • Annual Income, $ -21,650 K
  • EBIT $ -27 M
  • EBITDA $ -26 M
  • 60-Month Beta 0.27
  • Price/Sales 10.18
  • Price/Cash Flow N/A
  • Price/Book 1.92

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9200 +14.13%
on 11/24/25
2.0900 -49.76%
on 11/13/25
-0.2500 (-19.23%)
since 11/11/25
3-Month
0.9200 +14.13%
on 11/24/25
2.0900 -49.76%
on 11/13/25
-0.6300 (-37.50%)
since 09/11/25
52-Week
0.9200 +14.13%
on 11/24/25
8.2000 -87.20%
on 02/05/25
-4.2200 (-80.08%)
since 12/11/24

Most Recent Stories

More News
Analysts Offer Insights on Healthcare Companies: Nurix Therapeutics (NRIX) and Mainz Biomed B.V. (MYNZ)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Nurix Therapeutics (NRIX – Research Report) and Mainz Biomed B.V. (MYNZ – Research Report) with bullish...

NRIX : 19.07 (-2.75%)
MYNZ : 1.0500 (-4.55%)
Mainz Biomed Enters $10 Million Equity Distribution Agreement with Maxim Group

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Mainz Biomed...

MYNZ : 1.0500 (-4.55%)
Mainz Biomed Vs. Aurinia Pharma: Retail Traders Weigh In On The Better Biotech Bet

Over the past three months, Mainz has seen a staggering 2,500% increase in message volume on Stocktwits, while Aurinia’s engagement has grown just 23%.

AUPH : 15.88 (+2.65%)
MYNZ : 1.0500 (-4.55%)
Mainz Biomed Enters Agreement with Quest Diagnostics to Advance ColoAlert Colorectal Cancer Screening Test

Mainz Biomed partners with Quest Diagnostics to commercialize a colorectal cancer screening test, enhancing early detection efforts.Quiver AI SummaryMainz Biomed N.V. has announced a partnership with Quest...

MYNZ : 1.0500 (-4.55%)
Mainz Biomed N.V. Completes Follow-On Offering Raising Approximately $8 Million

Mainz Biomed closed a follow-on offering, raising approximately $8 million through the sale of 1,367,521 units.Quiver AI SummaryMainz Biomed N.V. has successfully completed a follow-on offering of 1,367,521...

MYNZ : 1.0500 (-4.55%)
Mainz Biomed N.V. Announces Pricing of Follow-On Offering to Raise Approximately $8.0 Million

Mainz Biomed announces $8 million follow-on offering of 1,367,521 units, including shares and warrants, priced at $5.85 each.Quiver AI SummaryMainz Biomed N.V. has announced a follow-on offering of 1,367,521...

MYNZ : 1.0500 (-4.55%)
Mainz Biomed Announces 1-for-40 Reverse Stock Split to Comply with Nasdaq Listing Standards

Mainz Biomed announces a 1-for-40 reverse stock split to meet Nasdaq listing standards, effective December 3, 2024.Quiver AI SummaryMainz Biomed N.V. has announced a 1-for-40 reverse stock split, effective...

MYNZ : 1.0500 (-4.55%)
Mainz Biomed Expands Commercial Footprint into Poland

Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today

MYNZ : 1.0500 (-4.55%)
Being Overweight or Obese Increases Risk of Developing Colorectal Cancer

Maintaining a healthy weight is important for general health, but growing evidence reveals obesity’s role in the development of chronic illnesses and even deadly cancers. Obesity is one of the most frequent...

MYNZ : 1.0500 (-4.55%)
BioNTech’s mRNA Vaccine Shows Early Potential Against Pancreatic Cancer

One of the most stubborn, deadly cancers is pancreatic cancer. What if individualized mRNA vaccinations could support the immune system’s defense? One of the deadliest forms of cancer around, pancreatic...

MYNZ : 1.0500 (-4.55%)

Business Summary

Mainz Biomed N.V. develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The Company's flagship product is ColoAlert, an accurate, non-invasive, and easy-to-use early detection diagnostic test for colorectal cancer. Mainz Biomed N.V. is based in BERKELEY, Calif....

See More

Key Turning Points

3rd Resistance Point 1.2333
2nd Resistance Point 1.1867
1st Resistance Point 1.1433
Last Price 1.0500
1st Support Level 1.0533
2nd Support Level 1.0067
3rd Support Level 0.9633

See More

52-Week High 8.2000
Fibonacci 61.8% 5.4190
Fibonacci 50% 4.5600
Fibonacci 38.2% 3.7010
Last Price 1.0500
52-Week Low 0.9200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar